Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ISM3412 |
| Synonyms | |
| Therapy Description |
ISM3412 is a selective MAT2A inhibitor, which potentially decreases tumor cell proliferation and inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 503). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ISM3412 | ISM-3412|ISM 3412 | ISM3412 is a selective MAT2A inhibitor, which potentially decreases tumor cell proliferation and inhibits tumor growth (Cancer Res (2023) 83 (7_Supplement): 503). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06414460 | Phase I | ISM3412 | Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors | Recruiting | USA | 1 |